Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Recruiting in Palo Alto (17 mi)
+32 other locations
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: AstraZeneca
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The study examines the Safety and efficacy study of exenatide once weekly in children and adolescents with type 2 diabetes
Eligibility Criteria
Inclusion Criteria
Each patient must meet the following criteria to be enrolled in this study.
Is a child or an adolescent of 10 to <18 years old, at Visit 1 (Screening)
Has been diagnosed with type 2 diabetes mellitus per American Diabetes Association diagnostic criteria
See 7 more
Treatment Details
Interventions
- Exenatide Once Weekly (Glucagon-like peptide-1 receptor agonist)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: EQWExperimental Treatment1 Intervention
Exenatide once weekly
Group II: PlaceboPlacebo Group1 Intervention
Placebo once weekly
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Research SiteLouisville, KY
Research SiteNew Haven, CT
Research SiteIowa City, IA
Research SiteKansas City, KS
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
AstraZenecaLead Sponsor